{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:47:05Z","timestamp":1790750825283,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.rmed.2020.105996","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T07:05:59Z","timestamp":1587971159000},"page":"105996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":157,"special_numbering":"C","title":["Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?"],"prefix":"10.1016","volume":"168","author":[{"given":"Fabio","family":"Perrotta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gabriella","family":"Matera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2020.105996_bib1","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology , genetic recombination , and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol."},{"issue":"Suppl","key":"10.1016\/j.rmed.2020.105996_bib2","first-page":"S9","article-title":"SARS: epidemiology","volume":"8","author":"Chan-Yeung","year":"2003","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2020.105996_bib3","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2020.105996_bib4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2020.105996_bib5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.rmed.2020.105996_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jmv.25682","article-title":"Cross-species transmission of the newly identified coronavirus 2019-nCoV","volume":"92","author":"Ji","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.rmed.2020.105996_bib7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/crj.12510","article-title":"Coinfections with influenza virus and atypical bacteria: implications for severe outcomes?","volume":"12","author":"Giannattasio","year":"2018","journal-title":"Clin. Res. J"},{"issue":"20","key":"10.1016\/j.rmed.2020.105996_bib8","first-page":"30229","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"S0092\u20138674","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.rmed.2020.105996_bib9","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.rmed.2020.105996_bib10","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.emboj.7600640","article-title":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2","volume":"24","author":"Li","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.rmed.2020.105996_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.11.032","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.rmed.2020.105996_bib12","first-page":"1","article-title":"Structure , function , and antigenicity of the SARS- structure , function , and antigenicity of the SARS-CoV-2 spike glycoprotein","author":"Glycoprotein","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.rmed.2020.105996_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.rmed.2020.105996_bib14","first-page":"1","article-title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","author":"Xu","year":"2020","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.rmed.2020.105996_bib15","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1373\/clinchem.2004.035436","article-title":"ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome","volume":"50","author":"Chiu","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.rmed.2020.105996_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.antiviral.2013.08.014","article-title":"Receptor recognition and cross-species infections of SARS coronavirus","volume":"100","author":"Li","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.rmed.2020.105996_bib17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.rmed.2020.105996_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.coph.2006.03.001","article-title":"Angiotensin-converting enzyme 2 in lung diseases","volume":"6","author":"Kuba","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.rmed.2020.105996_bib19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.rmed.2020.105996_bib20","doi-asserted-by":"crossref","first-page":"L156","DOI":"10.1152\/ajplung.00313.2002","article-title":"Angiotensin II and the fibroproliferative response to acute lung injury","volume":"286","author":"Marshall","year":"2004","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.rmed.2020.105996_bib21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2796.2008.01981.x","article-title":"Renin-angiotensin system revisited","volume":"264","author":"Fyhrquist","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.rmed.2020.105996_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","author":"Gurwitz","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.rmed.2020.105996_bib23","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-20-0451","article-title":"TMPRSS2 and COVID-19: serendipity or opportunity for intervention?","author":"Stopsack","year":"2020","journal-title":"Canc. Discov."},{"key":"10.1016\/j.rmed.2020.105996_bib24","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1128\/JVI.01542-10","article-title":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2","volume":"84","author":"Matsuyama","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.rmed.2020.105996_bib25","doi-asserted-by":"crossref","first-page":"9896 LP","DOI":"10.1128\/JVI.01118-06","article-title":"Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium","volume":"80","author":"B\u00f6ttcher","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.rmed.2020.105996_bib27","unstructured":"NCT04352400 C go I. Efficacy of Nafamostat in Covid-19 Patients (RACONA Study) (RACONA) (n.d)."},{"key":"10.1016\/j.rmed.2020.105996_bib28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2174\/1871528113666140713164506","article-title":"ACE and ACE2 in inflammation: a tale of two enzymes","volume":"13","author":"Gaddam","year":"2014","journal-title":"Inflamm. Allergy - Drug Targets"},{"key":"10.1016\/j.rmed.2020.105996_bib29","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02638-2017","article-title":"A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension","volume":"51","author":"Hemnes","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2020.105996_bib30","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1113\/expphysiol.2005.031096","article-title":"Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats","volume":"90","author":"Huentelman","year":"2005","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.rmed.2020.105996_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/SHK.0000000000000633","article-title":"Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease","volume":"46","author":"Jia","year":"2016","journal-title":"Shock"},{"key":"10.1016\/j.rmed.2020.105996_bib32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/08958378.2013.850563","article-title":"Angiotensin-converting enzyme-2 overexpression attenuates inflammation in rat model of chronic obstructive pulmonary disease","volume":"26","author":"Xue","year":"2014","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.rmed.2020.105996_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.taap.2016.06.026","article-title":"Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model","volume":"306","author":"Dhawale","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.rmed.2020.105996_bib34","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2020.105996_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China","author":"Zhang","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2020.105996_bib36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2249.2000.01301.x","article-title":"Expression of intercellular adhesion molecule-1 (ICAM-1) in nasal epithelial cells of atopic subjects: a mechanism for increased rhinovirus infection?","volume":"121","author":"Bianco","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.rmed.2020.105996_bib37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2020.105996_bib38","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.RES.0000187500.24964.7A","article-title":"Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients","volume":"97","author":"Keidar","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.rmed.2020.105996_bib39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.regpep.2010.09.005","article-title":"Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression","volume":"166","author":"Zhong","year":"2011","journal-title":"Regul. Pept."},{"key":"10.1016\/j.rmed.2020.105996_bib40","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.rmed.2020.105996_bib41","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension (Dallas)"},{"key":"10.1016\/j.rmed.2020.105996_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpu086","article-title":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker","volume":"28","author":"Furuhashi","year":"2015","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.rmed.2020.105996_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1470320315576256","article-title":"Activation of renin-angiotensin-aldosterone system (RAAS) in the lung of smoking-induced pulmonary arterial hypertension (PAH) rats","volume":"16","author":"Yuan","year":"2015","journal-title":"J. Renin-Angiotensin-Aldosterone Syst. JRAAS"},{"key":"10.1016\/j.rmed.2020.105996_bib44","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.rmed.2020.105996_bib45","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1038\/srep07027","article-title":"Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury","volume":"4","author":"Yang","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.rmed.2020.105996_bib46","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Correspondence hypertension and increased risk for","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir"},{"key":"10.1016\/j.rmed.2020.105996_bib47","article-title":"Association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","author":"Zhang","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.rmed.2020.105996_bib48","series-title":"Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers","author":"European Society of Cardiology (ESC)","year":"2020"},{"key":"10.1016\/j.rmed.2020.105996_bib49","series-title":"Heart Failure Society of America (HFSA) and American College of Cardiology (ACC). Patients Taking ACE-I and ARBs Who Contract COVID-19 Should Continue Treatment, unless Otherwise Advised by Their Physician","author":"American Heart Association (AHA)","year":"2020"},{"key":"10.1016\/j.rmed.2020.105996_bib50","series-title":"A Statement from the International Society of Hypertension on COVID-19","author":"International Society of Hypertension","year":"2020"},{"key":"10.1016\/j.rmed.2020.105996_bib51","doi-asserted-by":"crossref","DOI":"10.1007\/s40264-020-00935-2","article-title":"Should patients receiving ACE inhibitors or angiotensin receptor blockers be switched to other antihypertensive drugs to prevent or improve prognosis of novel coronavirus disease 2019 (COVID-19)?","author":"Trifir\u00f2","year":"2020","journal-title":"Drug Saf."},{"key":"10.1016\/j.rmed.2020.105996_bib52","series-title":"Statement of the European Society of Hypertension (ESH) on Hypertension, Renin Angiotensin System Blockers and COVID-19 March 19th 2020","author":"European Society of Hypertension","year":"2020"},{"key":"10.1016\/j.rmed.2020.105996_bib53","first-page":"m406","article-title":"Use of angiotensin receptor blockers such as Telmisartan, Losartsan in nCoV Wuhan Corona Virus infections \u2013 novel mode of treatment","volume":"368","author":"Phadke","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.rmed.2020.105996_bib54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000375362","article-title":"Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats","volume":"131","author":"Qiao","year":"2015","journal-title":"Cardiology"},{"key":"10.1016\/j.rmed.2020.105996_bib55","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejphar.2018.04.032","article-title":"Role of Wnt4\/beta-catenin, Ang II\/TGFbeta, ACE2, NF-kappaB, and IL-18 in attenuating renal ischemia\/reperfusion-induced injury in rats treated with Vit D and pioglitazone","volume":"831","author":"Ali","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.rmed.2020.105996_bib56","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S1665-2681(19)31294-3","article-title":"Pioglitazone upregulates hepatic angiotensin converting enzyme 2 expression in rats with steatohepatitis","volume":"12","author":"Zhang","year":"2013","journal-title":"Ann. Hepatol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120301360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120301360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:56:55Z","timestamp":1760615815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611120301360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":55,"alternative-id":["S0954611120301360"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2020.105996","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2020.105996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105996"}}